SUNNYVALE, Calif.--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, announced the expansion of its portfolio of radiofrequency ablation (RFA) catheters with ...
Leading health care products maker Covidien (NYSE:COV - News) is buying California-based privately held BARRX Medical in a bid to bolster its presence in gastrointestinal diseases therapy space. The ...
BARRX Medical Inc., a leader in developing minimally invasive medical devices used in conjunction with endoscopy to remove precancerous tissue from the gastrointestinal tract, announces today that ...
The BARRX buy will allow the company to expand its ability to treat gastrointestinal diseases, such as Barrett's esophagus. "In today's healthcare environment, patients, physicians, payers and ...
Health care major Covidien (NYSE:COV - News) has completed its takeover of California-based privately held BARRX Medical for roughly $325 million. The Ireland-based company forged a definitive deal to ...
Covidien has finalized a deal to acquire Barrx Medical for $325 million in cash, according to a Wall Street Journal report. The purchase brings Covidien into the gastroenterology field. Barrx will be ...
Barrx TM 360 Express RFA Balloon Catheter`s Adjustable Custom Fit Provides Targeted Precision Therapy - Allowing Physician Ease and Efficiency The Barrx 360 Express catheter, with its self-adjusting ...
DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire ...
Acquisition to expand presence in GI treatments BARRX a leader in treating Barrett's esophagus Deal seen closing Jan. 31 Nov 21 (Reuters) - Healthcare products and medical device maker Covidien Plc ...
Barrx Medical will donate $200,000 to ASGE’s Institute for Training & Technology Capital Campaign, a project to construct a new training facility, over a five-year period, according to an ASGE news ...
Leading health care products maker Covidien ( COV) is buying California-based privately held BARRX Medical in a bid to bolster its presence in gastrointestinal diseases therapy space. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results